Medical Care Technologies (OTCID:MDCE) Launches StrainScan Pro - Expanding AI Vision Platform into High-Value Agricultural & Food Quality Control Markets

Rhea-AI Summary

Medical Care Technologies (OTCID:MDCE) announced the public launch of StrainScan Pro, an AI-powered visual intelligence platform initially targeting cannabis dispensaries for strain identification and analysis. The system uses the company’s proprietary AI vision technology to provide rapid, accurate visual assessment.

According to the company, StrainScan Pro’s underlying computer-vision architecture is designed for broader quality-control applications in agriculture, food distribution, restaurants, grocery supply chains, and processing facilities. The launch aligns with Medical Care Technologies’ strategy to deploy its AI vision platform across multiple verticals while supporting non-dilutive capital generation through subsidiaries Infinite Auctions and Real Game Used.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

New AI-Powered Platform Targets Multi-Trillion-Dollar Agriculture and Food Supply Chain Opportunities Through Advanced Visual Identification and Quality Monitoring

MESA, AZ / ACCESS Newswire / August 5, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today announced the public launch of StrainScan Pro, an AI-powered visual intelligence platform initially focused on cannabis strain identification and analysis for dispensaries, with broader applications in agricultural quality control, food distribution, restaurants, and grocery supply-chain monitoring.

StrainScan Pro leverages the Company's proprietary AI vision technology to deliver rapid, accurate visual analysis. While the platform launches with specialized capabilities for the cannabis retail sector, its underlying computer-vision architecture is designed for expansion into quality-control use cases across the wider agricultural and food industries.

The global agriculture market represents one of the largest economic sectors worldwide, with gross production value measured in the multi-trillion-dollar range. Parallel opportunities exist in food safety and quality control, where AI-driven visual inspection systems are experiencing rapid adoption as companies seek greater efficiency, consistency, and risk reduction across markets, distribution centers, restaurants, and processing facilities.

"StrainScan Pro represents another practical application of our AI vision technology," said Marshall Perkins, CEO of Medical Care Technologies. "We are focused on building tools that solve real identification and quality-monitoring challenges. The same core capabilities that power StrainScan Pro can be applied to agricultural produce grading, food quality inspection, and supply-chain verification - markets of enormous scale."

The launch of StrainScan Pro continues Medical Care Technologies' strategy of deploying its AI vision platform across multiple verticals while generating non-dilutive capital through subsidiaries such as Infinite Auctions and Real Game Used.

Investors and industry participants can explore the platform at: https://strainscanpro.com

About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTCID:MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions. The Company also owns subsidiaries Infinite Auctions and Real Game Used, which provide complementary revenue-generating operations. Visit: https://medicalcaretechnologies.com

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current expectations and assumptions, and actual results may differ materially due to various risks and uncertainties. The company undertakes no obligation to update these statements except as required by law. Investors are cautioned not to place undue reliance on forward-looking statements.

Contact Information:
Medical Care Technologies Inc.
1910 S. Stapley Drive, Suite 221,
Mesa, AZ 85204
Phone: +1 (480) 645-0750
Email: marshall@medicalcaretechnologies.com
Websites: https://medicalcaretechnologies.com | https://strainscanpro.com

SOURCE: Medical Care Technologies Inc.

View the original press release on ACCESS Newswire

FAQ

What is StrainScan Pro launched by Medical Care Technologies (OTCID:MDCE) on August 5, 2026?

StrainScan Pro is an AI-powered visual intelligence platform for cannabis strain identification and analysis. According to Medical Care Technologies, it delivers rapid, accurate visual assessment using proprietary AI vision technology, initially targeting dispensaries but designed for broader quality-control applications.

How does StrainScan Pro use AI vision technology in the cannabis retail sector for MDCE?

StrainScan Pro applies proprietary AI vision to visually identify and analyze cannabis strains for dispensaries. According to Medical Care Technologies, the platform provides rapid, accurate visual analysis intended to address real identification and quality-monitoring challenges in cannabis retail environments.

Which markets beyond cannabis can StrainScan Pro from MDCE be applied to?

StrainScan Pro’s computer-vision architecture is designed for agriculture and food-related quality control. According to Medical Care Technologies, potential uses include agricultural produce grading, food quality inspection, and grocery and restaurant supply-chain verification across markets and distribution centers.

What strategic role does StrainScan Pro play in Medical Care Technologies’ (MDCE) AI platform strategy?

StrainScan Pro extends the company’s AI vision platform into additional commercial verticals. According to Medical Care Technologies, the launch supports a strategy of deploying AI applications across multiple sectors while leveraging subsidiaries Infinite Auctions and Real Game Used for non-dilutive capital.

How does Medical Care Technologies describe the market opportunity for StrainScan Pro and its AI vision platform?

Medical Care Technologies highlights agriculture as a multi-trillion-dollar sector with parallel opportunities in food safety and quality control. According to the company, AI-driven visual inspection systems are gaining adoption as firms seek efficiency, consistency, and risk reduction across supply chains.

Where can investors and industry participants access information about StrainScan Pro from MDCE?

Investors and industry participants can explore StrainScan Pro at the dedicated website. According to Medical Care Technologies, the platform is available at https://strainscanpro.com, providing additional details about its AI-powered visual identification and quality-monitoring capabilities.